Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00201760
Status:
COMPLETED
Last Update Posted:
2017-12-27
First Post:
2005-09-12
Brief Title:
Gemcitabine Trastuzumab and Gemcitabine Cisplatin Trastuzumab in Patients With Metastatic Breast Cancer
Sponsor:
Kari Kendra
Organization:
Ohio State University Comprehensive Cancer Center
Organization Data
Organization:
Ohio State University Comprehensive Cancer Center
Class:
OTHER
Study ID:
OSU-0342
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kari Kendra
Lead Sponsor Class:
OTHER
Responsible Party:
Kari Kendra
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Ohio State University Comprehensive Cancer Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eli Lilly and Company | INDUSTRY |